Published in Chem Commun (Camb) on September 28, 2010
Flow photochemistry: Old light through new windows. Beilstein J Org Chem (2012) 1.25
Continuous-flow catalytic asymmetric hydrogenations: Reaction optimization using FTIR inline analysis. Beilstein J Org Chem (2012) 0.98
Continuous flow photolysis of aryl azides: Preparation of 3H-azepinones. Beilstein J Org Chem (2011) 0.92
Efficient amide bond formation through a rapid and strong activation of carboxylic acids in a microflow reactor. Angew Chem Int Ed Engl (2013) 0.80
Micro-flow synthesis and structural analysis of sterically crowded diimine ligands with five aryl rings. Beilstein J Org Chem (2013) 0.80
Microphotochemistry: 4,4'-Dimethoxybenzophenone mediated photodecarboxylation reactions involving phthalimides. Beilstein J Org Chem (2011) 0.79
Photochemistry with laser radiation in condensed phase using miniaturized photoreactors. Beilstein J Org Chem (2012) 0.75
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol (2011) 21.49
Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res (2004) 18.86
A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res (2005) 10.46
Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res (2004) 7.76
Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence. J Clin Oncol (2005) 5.63
Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci (2005) 4.55
Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J Natl Cancer Inst (2002) 3.44
let-7 regulates Dicer expression and constitutes a negative feedback loop. Carcinogenesis (2008) 2.75
Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1. Cancer Res (2007) 2.59
Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res (2005) 2.48
Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors. J Clin Oncol (2006) 2.37
TTF-1 expression in pulmonary adenocarcinomas. Am J Surg Pathol (2002) 2.32
MicroRNAs in biological processes and carcinogenesis. Carcinogenesis (2006) 2.14
Identification of hypoxia-inducible factor-1 alpha as a novel target for miR-17-92 microRNA cluster. Cancer Res (2008) 2.08
Diameter and rigidity of multiwalled carbon nanotubes are critical factors in mesothelial injury and carcinogenesis. Proc Natl Acad Sci U S A (2011) 2.01
Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. J Infect Chemother (2010) 1.92
Variation in TP63 is associated with lung adenocarcinoma susceptibility in Japanese and Korean populations. Nat Genet (2010) 1.90
Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction. J Clin Oncol (2004) 1.89
Relapse-related molecular signature in lung adenocarcinomas identifies patients with dismal prognosis. J Clin Oncol (2009) 1.78
Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth. Cancer Res (2007) 1.73
NKX2-1/TITF1/TTF-1-Induced ROR1 is required to sustain EGFR survival signaling in lung adenocarcinoma. Cancer Cell (2012) 1.68
let-7 and miR-17-92: small-sized major players in lung cancer development. Cancer Sci (2011) 1.65
The patient health questionnaire, Japanese version: validity according to the mini-international neuropsychiatric interview-plus. Psychol Rep (2007) 1.55
Changes in colorectal cancer during a 20-year period: an extended report from the multi-institutional registry of large bowel cancer, Japan. Dis Colon Rectum (2003) 1.51
A rapid, sensitive assay to detect EGFR mutation in small biopsy specimens from lung cancer. J Mol Diagn (2006) 1.50
Reduced expression of class II histone deacetylase genes is associated with poor prognosis in lung cancer patients. Int J Cancer (2004) 1.50
Stereoselective synthesis of oligo-alpha-(2,8)-sialic acids. J Am Chem Soc (2006) 1.48
ASH1 gene is a specific therapeutic target for lung cancers with neuroendocrine features. Cancer Res (2005) 1.45
Epidermal growth factor receptor gene amplification is acquired in association with tumor progression of EGFR-mutated lung cancer. Cancer Res (2008) 1.42
EGFR mutation is specific for terminal respiratory unit type adenocarcinoma. Am J Surg Pathol (2005) 1.42
Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at 21q11-21 in human lung cancer. Genes Chromosomes Cancer (2008) 1.41
Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients. Oncogene (2004) 1.41
Isolation of Helicobacter cinaedi from blood of an immunocompromised patient in Japan. J Infect Chemother (2003) 1.38
Bronchial casts and pandemic (H1N1) 2009 virus infection. Emerg Infect Dis (2010) 1.37
Expression of cancer/testis (CT) antigens in lung cancer. Lung Cancer (2003) 1.31
Roles of achaete-scute homologue 1 in DKK1 and E-cadherin repression and neuroendocrine differentiation in lung cancer. Cancer Res (2008) 1.30
A 25-signal proteomic signature and outcome for patients with resected non-small-cell lung cancer. J Natl Cancer Inst (2007) 1.30
Chromosome instability in human lung cancers: possible underlying mechanisms and potential consequences in the pathogenesis. Oncogene (2002) 1.29
Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers. Oncogene (2002) 1.29
Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer. Oncogene (2002) 1.28
Frequent and histological type-specific inactivation of 14-3-3sigma in human lung cancers. Oncogene (2002) 1.28
Expression profiling of genes regulated by TGF-beta: differential regulation in normal and tumour cells. BMC Genomics (2007) 1.25
Down-regulation of DUSP6 expression in lung cancer: its mechanism and potential role in carcinogenesis. Am J Pathol (2009) 1.24
Tumor cell-derived angiopoietin-like protein ANGPTL2 is a critical driver of metastasis. Cancer Res (2012) 1.23
Evolved diversification of a modular natural product pathway: apratoxins F and G, two cytotoxic cyclic depsipeptides from a Palmyra collection of Lyngbya bouillonii. Chembiochem (2010) 1.22
NKX2-1/TTF-1: an enigmatic oncogene that functions as a double-edged sword for cancer cell survival and progression. Cancer Cell (2013) 1.22
Traditional chinese medicine for chronic fatigue syndrome. Evid Based Complement Alternat Med (2008) 1.19
Significant up-regulation of a novel gene, CLCP1, in a highly metastatic lung cancer subline as well as in lung cancers in vivo. Oncogene (2002) 1.19
Clinically relevant characterization of lung adenocarcinoma subtypes based on cellular pathways: an international validation study. PLoS One (2010) 1.18
Measurement of in vivo local shear modulus using MR elastography multiple-phase patchwork offsets. IEEE Trans Biomed Eng (2003) 1.18
Nongenomic beta estrogen receptors enhance beta1 adrenergic signaling induced by the nicotine-derived carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human small airway epithelial cells. Cancer Res (2007) 1.18
Association between mitotic spindle checkpoint impairment and susceptibility to the induction of apoptosis by anti-microtubule agents in human lung cancers. Am J Pathol (2003) 1.17
MYBPH, a transcriptional target of TTF-1, inhibits ROCK1, and reduces cell motility and metastasis. EMBO J (2011) 1.17
Interleukin-6 and cardiovascular diseases. Jpn Heart J (2004) 1.14
Neurotensin receptor 1 determines the outcome of non-small cell lung cancer. Clin Cancer Res (2010) 1.14
Identification of decatenation G2 checkpoint impairment independently of DNA damage G2 checkpoint in human lung cancer cell lines. Cancer Res (2004) 1.13
Homozygous deletion of CDKN2A/2B is a hallmark of iron-induced high-grade rat mesothelioma. Lab Invest (2010) 1.12
hDREF regulates cell proliferation and expression of ribosomal protein genes. Mol Cell Biol (2007) 1.12
Silent information regulator, Sirtuin 1, and age-related diseases. Geriatr Gerontol Int (2009) 1.12
miR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer. Cancer Res (2011) 1.10
One-pot synthesis of sialo-containing glycosyl amino acids by use of an N-trichloroethoxycarbonyl-beta-thiophenyl sialoside. Chemistry (2005) 1.10
K-ras gene mutation enhances motility of immortalized airway cells and lung adenocarcinoma cells via Akt activation: possible contribution to non-invasive expansion of lung adenocarcinoma. Am J Pathol (2004) 1.10
Direct evidence for the dirac-cone topological surface states in the ternary chalcogenide TlBiSe₂. Phys Rev Lett (2010) 1.09
Cell cycle activation in lung adenocarcinoma cells by the ErbB3/phosphatidylinositol 3-kinase/Akt pathway. Carcinogenesis (2003) 1.09
A formal total synthesis of taxol aided by an automated synthesizer. Chem Asian J (2006) 1.08
Inhibition of cell survival, invasion, tumor growth and histone deacetylase activity by the dietary flavonoid luteolin in human epithelioid cancer cells. Eur J Pharmacol (2010) 1.08
Iron overload signature in chrysotile-induced malignant mesothelioma. J Pathol (2012) 1.08
Concern Differential inactivation of caspase-8 in lung cancers. Cancer Biol Ther (2002) 1.07
Endogenous angiogenesis inhibitor vasohibin1 exhibits broad-spectrum antilymphangiogenic activity and suppresses lymph node metastasis. Am J Pathol (2010) 1.06
Significant growth inhibition of human lung cancer cells both in vitro and in vivo by the combined use of a selective cyclooxygenase 2 inhibitor, JTE-522, and conventional anticancer agents. Clin Cancer Res (2002) 1.06
Tetraspanin CD151 regulates transforming growth factor beta signaling: implication in tumor metastasis. Cancer Res (2010) 1.04
Maspin expression in normal lung and non-small-cell lung cancers: cellular property-associated expression under the control of promoter DNA methylation. Oncogene (2004) 1.02
Outbreak of human metapneumovirus infection in elderly inpatients in Japan. J Am Geriatr Soc (2006) 1.01
A novel target gene, SKP2, within the 5p13 amplicon that is frequently detected in small cell lung cancers. Am J Pathol (2002) 1.00
Fenton reaction induced cancer in wild type rats recapitulates genomic alterations observed in human cancer. PLoS One (2012) 1.00
Expression of CD109 in human cancer. Oncogene (2004) 1.00
Expression of chromobox homolog 7 (CBX7) is associated with poor prognosis in ovarian clear cell adenocarcinoma via TRAIL-induced apoptotic pathway regulation. Int J Cancer (2014) 0.99
Thymoquinone as an anticancer agent: evidence from inhibition of cancer cells viability and invasion in vitro and tumor growth in vivo. Fundam Clin Pharmacol (2012) 0.99
Peculiar Rashba splitting originating from the two-dimensional symmetry of the surface. Phys Rev Lett (2009) 0.99
Direct and stereoselective synthesis of beta-linked 2,6-deoxyoligosaccharides. Angew Chem Int Ed Engl (2007) 0.99
Acupuncture regulates leukocyte subpopulations in human peripheral blood. Evid Based Complement Alternat Med (2007) 0.98
LKB1 gene mutations in Japanese lung cancer patients. Cancer Sci (2007) 0.98
Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer. Int J Cancer (2003) 0.97
Differential toxicogenomic responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin in malignant and nonmalignant human airway epithelial cells. Toxicol Sci (2002) 0.97
β-galactosyl Yariv reagent binds to the β-1,3-galactan of arabinogalactan proteins. Plant Physiol (2013) 0.97
Palladium-catalysed direct synthesis of benzo[b]thiophenes from thioenols. Chem Commun (Camb) (2008) 0.96
Down-regulation of SKP2 induces apoptosis in lung-cancer cells. Cancer Sci (2003) 0.96
Acute disseminated encephalomyelitis following Plasmodium vivax malaria. J Infect Chemother (2003) 0.96
Synthesis of di-branched heptasaccharide by one-pot glycosylation using seven independent building blocks. Org Lett (2002) 0.96
CK20 expression, CDX2 expression, K-ras mutation, and goblet cell morphology in a subset of lung adenocarcinomas. J Pathol (2004) 0.95
Palladium-catalyzed synthesis of 2-substituted benzothiazoles via a C-H functionalization/intramolecular C-S bond formation process. Org Lett (2008) 0.95
Stereoselective Synthesis of alpha(2,9) Di- to Tetrasialic Acids, Using a 5,4-N,O-Carbonyl Protected Thiosialoside. J Org Chem (2009) 0.95
Efficient stereoselective synthesis of gamma-N-glycosyl asparagines by N-glycosylation of primary amide groups. J Am Chem Soc (2005) 0.94
Roles of POLD4, smallest subunit of DNA polymerase delta, in nuclear structures and genomic stability of human cells. Biochem Biophys Res Commun (2009) 0.94
Relationship of deregulated signaling converging onto mTOR with prognosis and classification of lung adenocarcinoma shown by two independent in silico analyses. Cancer Res (2009) 0.94
Total synthesis of (R)-telomestatin. Org Lett (2006) 0.94
Growth regulation via insulin-like growth factor binding protein-4 and -2 in association with mutant K-ras in lung epithelia. Am J Pathol (2006) 0.93
A flavonoid from Brassica rapa flower as the UV-absorbing nectar guide. Phytochemistry (2002) 0.93
Total synthesis of spiruchostatin B aided by an automated synthesizer. Org Biomol Chem (2011) 0.93